Amino Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is L-TYROSINE, with a corresponding US DMF Number 4649.
Remarkably, this DMF maintains an Active status since its submission on July 16, 1982, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 11, 2019, and payment made on December 17, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II